1,322
Views
20
CrossRef citations to date
0
Altmetric
Research Paper

The development of animal infection models and antifungal efficacy assays against clinical isolates of Trichosporon asahii, T. asteroides and T. inkin

, , , , , & show all
Pages 476-486 | Received 03 Sep 2014, Accepted 10 Feb 2015, Published online: 29 May 2015

References

  • Araujo Ribeiro M, Alastruey-Izquierdo A, Gomez-Lopez A, Rodriguez-Tudela JL, Cuenca-Estrella M. Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital. Rev Iberoam Micol 2008; 25:221-5; PMID:19071890; http://dx.doi.org/10.1016/S1130-1406(08)70053-6
  • Colombo AL, Padovan AC, Chaves GM. Current knowledge of Trichosporon spp and Trichosporonosis. Clin Microbiol Rev 2011; 24:682-700; PMID:21976604; http://dx.doi.org/10.1128/CMR.00003-11
  • Cafarchia C, Romito D, Coccioli C, Camarda A, Otranto D. Phospholipase activity of yeasts from wild birds and possible implications for human disease. Med Mycol 2008; 46:429-34; PMID:18608940; http://dx.doi.org/10.1080/13693780701885636
  • Fuentefria AM, Suh SO, Landell MF, Faganello J, Schrank A, Vainstein MH, Blackwell M, Valente P. Trichosporon insectorum sp. nov., a new anamorphic basidiomycetous killer yeast. Mycol Res 2008; 112:93-9; PMID:18222677; http://dx.doi.org/10.1016/j.mycres.2007.05.001
  • Gueho E, Smith MT, de Hoog GS. Trichosporon Behrend, p. 854-72. In C. P. Kurtzman and J. W. Fell (ed.), The Yeasts, a Taxonomic Study, 1998, 4th ed. Elsevier, Amsterdam, The Netherlands.
  • Haupt HM, Merz WG, Beschorner WE, Vaughan WP, Saral R. Colonization and infection with Trichosporon species in the immunosuppressed host. J Infect Dis 1983; 147:199-203; PMID:6827136; http://dx.doi.org/10.1093/infdis/147.2.199
  • Kwon-Chung KJ, Bennett JE. Medical Mycology, 1992. Lea & Febiger, Philadelphia, PA.
  • Lussier N, Laverdiere M, Delorme J, Weiss K, Dandavino R. Trichosporon beigelii funguria in renal transplant recipients. Clin Infect Dis 2000; 31:1299-301; PMID:11073770; http://dx.doi.org/10.1086/317463
  • Silvestre AM Jr, Miranda MAR, Camargo ZP. Trichosporon species isolated from the perigenital region, urine and catheters of a Brazilian population. Braz J Microbiol 2010; 41:628-34; PMID:24031538; http://dx.doi.org/10.1590/S1517-83822010000300013
  • Sugita T, Kikuchi K, Makimura K, Urata K, Someya T, Kamei K, Niimi M, Uehara Y. Trichosporon species isolated from guano samples obtained from bat-inhabited caves in Japan. Appl Environ Microbiol 2005; 71:7626-9; PMID:16269819; http://dx.doi.org/10.1128/AEM.71.11.7626-7629.2005
  • Walsh TJ. Role of surveillance cultures in prevention and treatment of fungal infections. NCI Monogr 1990; 9:43-5; PMID:2342594
  • Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10 Suppl 1:48-66; PMID:14748802; http://dx.doi.org/10.1111/j.1470-9465.2004.00839.x
  • Benson PM, Lapins NA, Odom RB. White piedra. Arch Dermatol 1983; 119:602-4; PMID:6859904; http://dx.doi.org/10.1001/archderm.1983.01650310064013
  • Kiken DA, Sekaran A, Antaya RJ, Davis A, Imaeda S, Silverberg NB. White piedra in children. J Am Acad Dermatol 2006; 55:956-61; PMID:17097391; http://dx.doi.org/10.1016/j.jaad.2005.11.1033
  • Kontoyiannis DP, Torres HA, Chagua M, Hachem R, Tarrand JJ, Bodey GP, Raad II. Trichosporonosis in a tertiary care cancer center: risk factors, changing spectrum and determinants of outcome. Scand J Infect Dis 2004; 36:564-9; PMID:15370667; http://dx.doi.org/10.1080/00365540410017563
  • Roshan AS, Janaki C, Parveen B. White piedra in a mother and daughter. Int J Trichol 2009; 1:140-1; PMID:20927238; http://dx.doi.org/10.4103/0974-7753.58559
  • Sano M, Sugitani M, Ishige T, Homma T, Kikuchi K, Sunagawa K, Obana Y, Uehara Y, Kumasaka K, Uenogawa K, et al. Supplemental utility of nested PCR for the pathological diagnosis of disseminated trichosporonosis. Virchows Arch 2007; 451:929-35; PMID:17786472; http://dx.doi.org/10.1007/s00428-007-0484-6
  • Youker SR, Andreozzi RJ. White piedra: further evidence of a synergistic infection. J Am Acad Dermatol 2003; 49:746-9.
  • Chagas-Neto, TC, Chaves GM, Melo AS, Colombo AL. Bloodstream infections due to Trichosporon spp.: species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J Clin Microbiol 2009; 47:1074-81; PMID:19225102; http://dx.doi.org/10.1128/JCM.01614-08
  • Di Bonaventura G, Pompilio A, Picciani C, Iezzi M, D'Antonio D, Piccolomini R. Biofilm formation by the emerging fungal pathogen Trichosporon asahii: development, architecture, and antifungal resistance. Antimicrob Agents Chemother 2006; 50:3269-76; PMID:17005804; http://dx.doi.org/10.1128/AAC.00556-06
  • Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B, Pastore D, Picardi M, Bonini A, Chierichini A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91:1068-75; PMID:16885047
  • Iturrieta-González IA, Padovan AC, Bizerra FC, Hahn RC, Colombo AL. Multiple species of trichosporon produce biofilms highly resistant to triazoles and amphotericin B. PLoS One 2014; 9:e109553; http://dx.doi.org/10.1371/journal.pone.0109553
  • Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 2000; 13:122-43; PMID:10627494; http://dx.doi.org/10.1128/CMR.13.1.122-143.2000
  • Mizobe T, Ando M, Yamasaki H, Onoue K, Misaki A. Purification and characterization of the serotype-specific polysaccharide antigen of Trichosporon cutaneum serotype II: a disease-related antigen of Japanese summer-type hypersensitivity pneumonitis. Clin Exp Allergy 1995; 25:265-72; PMID:7540499; http://dx.doi.org/10.1111/j.1365-2222.1995.tb01039.x
  • Rodrigues ML, Fonseca FL, Frases S, Casadevall A, Nimrichter L. The still obscure attributes of cryptococcal glucuronoxylomannan. Med Mycol 2009; 47:783-8; PMID:19343609; http://dx.doi.org/10.3109/13693780902788621
  • Chagas-Neto TC, Chaves GM, Melo ASA, Colombo AL. Bloodstream infections due to Trichosporon spp.: Species distribution, Trichosporon asahii genotypes determined on the basis of ribosomal DNA intergenic spacer 1 sequencing, and antifungal susceptibility testing. J Clin Microbiol 2009; 47:1074-81; PMID:19225102; http://dx.doi.org/10.1128/JCM.01614-08
  • Itoh T, Hosokawa H, Kohdera U, Toyazaki N, Asada Y. Disseminated infection with Trichosporon asahii. Mycoses 1996; 39:195-9; PMID:8909029; http://dx.doi.org/10.1111/j.1439-0507.1996.tb00124.x
  • Ruan SY, Chien JY, Hsueh PR. Invasive trichosporonosis caused by Trichosporon asahii and other unusual Trichosporon species at a medical center in Taiwan. Clin Infect Dis 2009; 49:e11-e17; PMID:19489711; http://dx.doi.org/10.1086/599614
  • Chaumentin G, Boibieux A, Piens MA, Douchet C, Buttard P, Bertrand JL, Peyramond D. Trichosporon inkin endocarditis: short-term evolution and clinical report. Clin Infect Dis 1996; 23:396-7; PMID:8842284; http://dx.doi.org/10.1093/clinids/23.2.396
  • Lopes JO, Alves SH, Klock C, Oliveira LT, Dal Forno NR. Trichosporon inkin peritonitis during continuous ambulatory peritoneal dialysis with bibliography review. Mycopathologia 1997; 139:15-8; PMID:9511232; http://dx.doi.org/10.1023/A:1006870017725
  • Steinbach WJ, Perfect JR. Newer antifungal therapy for emerging fungal pathogens. Int J Infect Dis 2003; 7:525; http://dx.doi.org/10.1016/S1201-9712(03)90037-3
  • Tokimatsu I, Kushima H, Hashinaga K, Umeki K, Ohama M, Ishii H, Kishi K, Hiramatsu K, Kadota J. The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model. Int J Antimicrob Agents 2007; 29:84-8; PMID:17189098; http://dx.doi.org/10.1016/j.ijantimicag.2006.09.013
  • Yang RY, Wang WL, Ao JH, Hao ZF, Zhang J, Wang CM. Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis. Chin Med J (Engl) 2008; 121:2557-60; PMID:19187595
  • Serena C, Gilgado F, Mariné M, Pastor FJ, Guarro J. Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis. Antimicrob Agents Chemother 2006; 50:2240-3; PMID:16723595; http://dx.doi.org/10.1128/AAC.00045-06
  • Lacy SH, Gardner DJ, Olson LC, Ding L, Holland SM, Bryant MA. Disseminated trichosporonosis in a murine model of chronic granulomatous disease. Comp Med 2003; 53:303-8; PMID:12868577
  • Tokimatsu I, Kushima H, Hashinaga K, Umeki K, Ohama M, Ishii H, Kishi K, Hiramatsu K, Kadota J. The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model. Int J Antimicrob Agents 2007; 29:84-8; PMID:17189098; http://dx.doi.org/10.1016/j.ijantimicag.2006.09.013
  • Dörlemann A, Listemann H, Iglauer F. Invasive Trichosporon beigelii infection in immunosuppressed rats. Mycoses 1994; 37:109-16; PMID:7845415; http://dx.doi.org/10.1111/j.1439-0507.1994.tb00785.x
  • Yamamoto K, Makimura K, Sudo T, Shibuya K, Uchida K, Yamaguchi H. Experimental disseminated trichosporonosis in mice: tissue distribution and therapy with antifungal agents. J Med Vet Mycol 1997; 35:411-8; PMID:9467108; http://dx.doi.org/10.1080/02681219780001511
  • Hospenthal D, Belay T, Lappin P, Rogers A, Kennedy M. Disseminated trichosporonosis in a neutropenic murine model. Mycopathologia 1993; 122:115-22; PMID:8327000; http://dx.doi.org/10.1007/BF01103609
  • Metin DY, Hilmioglu-Polat S, Hakim F, Inci R, Tumbay E. Evaluation of the microdilution, Etest and disk diffusion methods for antifungal susceptibility testing of clinical strains of Trichosporon spp. J Chemother 2005; 17:404-8; PMID:16167520; http://dx.doi.org/10.1179/joc.2005.17.4.404
  • Mylonakis E, Moreno R, El Khoury JB, Idnurm A, Heitman J, Calderwood SB, Ausubel FM, Diener A. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun 2005; 73:3842-50; PMID:15972469; http://dx.doi.org/10.1128/IAI.73.7.3842-3850.2005
  • Li DD, Deng L, Hu GH, Zhao LX, Hu DD, Jiang YY, Wang Y. Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents. Biol Pharm Bull 2013; 36:1482-7; PMID:23995660; http://dx.doi.org/10.1248/bpb.b13-00270
  • Ortoneda M, Guarro J, Madrid MP, Caracuel Z, Roncero MI, Mayayo E, Di Pietro A. Fusarium oxysporum as a multihost model for the genetic dissection of fungal virulence in plants and mammals. Infect Immun 2004; 72:1760-6; PMID:14977985; http://dx.doi.org/10.1128/IAI.72.3.1760-1766.2004
  • Gueho E, Improvisi L, de Hoog GS, Dupont B. Trichosporon on humans: a practical account. Mycoses 1994; 37:3-10; PMID:7935589; http://dx.doi.org/10.1111/j.1439-0507.1994.tb00277.x
  • Girmenia C, Pagano L, Martino B, D’Antonio D, Fanci R, Specchia G, Melillo L, Buelli M, Pizzarelli G, Venditti M, et al. Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature. J Clin Microbiol 2005; 43:1818-28; PMID:15815003; http://dx.doi.org/10.1128/JCM.43.4.1818-1828.2005
  • CLSI. Reference method for broth dilution antifungal susceptibility testing of yeasts, fourth informational supplement.CLSI document M27-S4. Wayne, PA: Clinical and Laboratory Standards Institute; 2012.
  • Guinea J, Recio S, Escribano P, Peláez T, Gama B, Bouza E. In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogens. Antimicrob Agents Chemother 2010; 54:4012-5; PMID:20566770; http://dx.doi.org/10.1128/AAC.00685-10
  • Madariaga MG, Tenorio A, Proia L. Trichosporon inkin peritonitis treated with caspofungin. J Clin Microbiol 2003; 41:5827-9; PMID:14662994; http://dx.doi.org/10.1128/JCM.41.12.5827-5829.2003
  • Bassetti M, Bisio F, Di Biagio A, Pierri I, Balocco M, Soro O, Cruciani M, Bassetti D. Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B. J Antimicrob Chemother 2004; 54:575-7; PMID:15231763; http://dx.doi.org/10.1093/jac/dkh337
  • Lionakis MS. Drosophila and Galleria insect model hosts: new tools for the study of fungal virulence, pharmacology and immunology. Virulence 2011; 2:521-7; PMID:22186764; http://dx.doi.org/10.4161/viru.2.6.18520
  • Anaissie EJ, Hachem R, Karyotakis NC, Gokaslan A, Dignani MC, Stephens LC, Tin-U CK. Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis. Antimicrob Agents Chemother 1994; 38:2541-4; PMID:7872744; http://dx.doi.org/10.1128/AAC.38.11.2541
  • Serena C, Pastor FJ, Gilgado F, Mayayo E, Guarro J. Efficacy of micafungin in combination with other drugs in a murine model of disseminated trichosporonosis. Antimicrob Agents Chemother 2005; 49:497-02; PMID:15673724; http://dx.doi.org/10.1128/AAC.49.2.497-502.2005
  • Serena C, Gilgado F, Mariné M, Pastor FJ, Guarro J. Efficacy of voriconazole in a guinea pig model of invasive trichosporonosis. Antimicrob Agents Chemother 2006; 50:2240-3; PMID:16723595; http://dx.doi.org/10.1128/AAC.00045-06
  • Treviño-Rangel RD, López LJ, Palma-Nicolás JP, Hernández-Bello R, González JG, González GM. Therapeutic efficacy of posaconazole in a murine model of disseminated trichosporonosis. J Antimicrob Chemother 2014; 69:1075-8; http://dx.doi.org/10.1093/jac/dkt466
  • Silvestre AM Jr., Miranda MAR, Camargo ZP. Trichosporon species isolated from the perigenital region, urine and catheters of a Brazilian population. Braz J Microbiol 2010; 41:628-34; PMID:24031538; http://dx.doi.org/10.1590/S1517-83822010000300013
  • Sugar AM, Liu XP. Effect of grapefruit juice on serum voriconazole concentrations in the mouse. Med Mycol 2000; 38:209-12; PMID:10892988; http://dx.doi.org/10.1080/mmy.38.3.209.212
  • CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, Approved Standard. CLSI Document M27-A3. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
  • Fuchs BB, O’Brien E, Khoury JB, Mylonakis E. Methods for using Galleria mellonella as a model host to study fungal pathogenesis. Virulence 2010; 1:475-82; PMID:21178491; http://dx.doi.org/10.4161/viru.1.6.12985
  • Fallon J, Kelly J, Kavanagh K. Galleria mellonella as a model for fungal pathogenicity testing. Methods Mol Biol 2012; 845:469–85; PMID:22328396; http://dx.doi.org/10.1007/978-1-61779-539-8_33
  • Arvanitis M, Fuchs BB, Mylonakis E. Nonmammalian model systems to investigate fungal biofilms. Methods Mol Biol 2014;1147:159-72; PMID:24664832; http://dx.doi.org/10.1007/978-1-4939-0467-9_11
  • Serena C, Pastor FJ, Mariné M, Rodríguez MM, Guarro J. Efficacy of voriconazole in a murine model of cryptococcal central nervous system infection. J Antimicrob Chemother 2007; 61:877-9; http://dx.doi.org/10.1093/jac/dkn012
  • Rodríguez MM, Calvo E, Serena C, Mariné M, Pastor FJ, Guarro J. Effects of double and triple combinations of antifungal drugs in a murine model of disseminated infection by Scedosporium prolificans. Antimicrob Agents Chemother 2009; 53:2153-5; http://dx.doi.org/10.1128/AAC.01477-08

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.